Revenue
$1.38B
Fiscal year ended 2026-09-30Operating income
$155.00M
Fiscal year ended 2026-09-30Free cash flow
$178.00M
Fiscal year ended 2026-09-30Valuation, from the filing
| Public float | $556.99M | Market value of stock held by non-affiliates, as stated on the cover page for 2025-06-30 |
|---|---|---|
| Float per share | $1.57 | Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself. |
| Float / revenue | 0.1× | A lower bound on the multiple, because affiliate holdings are excluded. |
| Float / equity | 0.1× | A lower bound on the multiple, because affiliate holdings are excluded. |
Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.
How this compares in its industry
Percentile among the Ophthalmic Goods filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.
| Measure | Reported | Percentile | |
|---|---|---|---|
| Current ratio | 1.55x | 17th | |
| CapEx / revenue | 6.8% | 67th | |
| SBC / revenue | 2.9% | 33th | |
| Operating margin | 2.2% | 60th | |
| FCF margin | -1.3% | 50th | |
| Net margin | -7.1% | 50th | |
| Revenue YoY growth | 6.5% | 50th |
Bausch & Lomb Corp (BLCO) reported revenue of $1.38B and net income of $32.00M for the fiscal year ended 2026-09-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Bausch & Lomb Corp’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Ophthalmic Goods.
Income
| Metric | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.38B | $1.39B | $1.24B | $1.40B | $1.28B | $1.28B | $1.14B | $1.28B | $1.20B | $1.22B |
| Cost of revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross profit | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating income | $155.00M | $83.00M | $33.00M | $112.00M | $95.00M | -$11.00M | -$83.00M | $87.00M | $43.00M | $26.00M |
| Net income | $32.00M | -$14.00M | -$71.00M | -$58.00M | -$28.00M | -$62.00M | -$212.00M | -$3.00M | $4.00M | -$151.00M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 361.50M | shares 357.10M | shares 355.20M | Unavailable | shares 354.20M | shares 353.70M | shares 352.80M | Unavailable | shares 353.90M | shares 351.80M |
| Pretax income | $58.00M | -$11.00M | -$64.00M | $13.00M | -$3.00M | -$147.00M | -$180.00M | -$10.00M | -$58.00M | -$76.00M |
| Income tax expense | $23.00M | -$1.00M | $6.00M | $71.00M | $22.00M | -$89.00M | $31.00M | -$8.00M | -$66.00M | $72.00M |
| Diluted EPS | $0.09 | $-0.04 | $-0.20 | Unavailable | $-0.08 | $-0.18 | $-0.60 | Unavailable | $0.01 | $-0.43 |
| Selling, general & administrative | $556.00M | $588.00M | $544.00M | $564.00M | $528.00M | $579.00M | $563.00M | $532.00M | $511.00M | $535.00M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $513.00M | $367.00M | $268.00M | $383.00M | $310.00M | $266.00M | $202.00M | $305.00M | $329.00M | $285.00M |
| Total assets | $13.96B | $13.86B | $13.78B | $14.02B | $13.83B | $13.83B | $13.43B | $13.47B | $13.52B | $13.25B |
| Current assets | $3.06B | $2.92B | $2.78B | $2.98B | $2.86B | $2.85B | $2.69B | $2.79B | $2.83B | $2.77B |
| Total liabilities | $7.45B | $7.42B | $7.33B | $7.50B | $7.33B | $7.32B | $7.00B | $6.92B | $6.85B | $6.67B |
| Current liabilities | $1.96B | $1.89B | $1.82B | $1.92B | $1.90B | $1.84B | $1.73B | $1.74B | $1.80B | $1.68B |
| Total equity incl. NCI | $6.51B | $6.44B | $6.45B | $6.52B | $6.50B | $6.51B | $6.43B | $6.54B | $6.66B | $6.58B |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $1.01B | $999.00M | $977.00M | $976.00M | $1.00B | $1.05B | $1.03B | $1.04B | $1.12B | $1.07B |
| Accounts receivable | $1.15B | $1.16B | $1.11B | $1.22B | $1.09B | $1.08B | $1.01B | $1.03B | $943.00M | $986.00M |
| Goodwill | $4.71B | $4.72B | $4.74B | $4.76B | $4.66B | $4.67B | $4.57B | $4.52B | $4.58B | $4.54B |
| Long-term debt | $4.99B | $5.05B | $5.01B | $5.02B | $4.92B | $4.93B | $4.79B | $4.74B | $4.60B | $4.60B |
| Accounts payable | $367.00M | $426.00M | $407.00M | $388.00M | $395.00M | $449.00M | $427.00M | $389.00M | $455.00M | $405.00M |
Cash flow
| Metric | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $233.00M | $153.00M | $32.00M | $136.00M | $137.00M | $35.00M | -$25.00M | $22.00M | $154.00M | $15.00M |
| Capital expenditures | $55.00M | $71.00M | $100.00M | $76.00M | $74.00M | $89.00M | $110.00M | $92.00M | $60.00M | $72.00M |
| Investing cash flow | -$73.00M | -$87.00M | -$130.00M | -$188.00M | -$61.00M | -$90.00M | -$116.00M | -$185.00M | -$96.00M | -$74.00M |
| Financing cash flow | -$22.00M | $34.00M | -$20.00M | $116.00M | -$12.00M | $90.00M | $31.00M | $146.00M | -$20.00M | $40.00M |
| Net change in cash | $137.00M | $99.00M | -$118.00M | $65.00M | $60.00M | $57.00M | -$101.00M | -$34.00M | $48.00M | -$23.00M |
| Stock-based compensation | $37.00M | $38.00M | $34.00M | $64.00M | $27.00M | $30.00M | $28.00M | $27.00M | $24.00M | $22.00M |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | $102.00M | $102.00M | $101.00M | $99.00M | $109.00M | $107.00M | $106.00M | $106.00M | $110.00M | $110.00M |
Derived
| Metric | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $178.00M | $82.00M | -$68.00M | $60.00M | $63.00M | -$54.00M | -$135.00M | -$70.00M | $94.00M | -$57.00M |
| Gross margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating margin | 11.3% | 6.0% | 2.7% | 8.0% | 7.4% | -0.9% | -7.3% | 6.8% | 3.6% | 2.1% |
| FCF margin | 12.9% | 5.9% | -5.5% | 4.3% | 4.9% | -4.2% | -11.9% | -5.5% | 7.9% | -4.7% |
| SBC / revenue | 2.7% | 2.7% | 2.7% | 4.6% | 2.1% | 2.3% | 2.5% | 2.1% | 2.0% | 1.8% |
| Current ratio | 1.56x | 1.55x | 1.53x | 1.55x | 1.51x | 1.55x | 1.56x | 1.60x | 1.57x | 1.65x |
| Revenue YoY growth | 7.3% | 9.1% | 9.4% | 9.8% | 7.1% | 5.1% | 3.5% | 9.1% | 18.8% | 17.5% |
| Net margin | 2.3% | -1.0% | -5.7% | -4.1% | -2.2% | -4.9% | -18.6% | -0.2% | 0.3% | -12.4% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 4.0% | 5.1% | 8.0% | 5.4% | 5.8% | 7.0% | 9.7% | 7.2% | 5.0% | 5.9% |
| Long-term debt / equity | 0.77x | Unavailable | Unavailable | 0.77x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 39.7% | Unavailable | Unavailable | 546.2% | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open BLCO in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-10-28View SEC filing
10-Q · Filed 2026-07-29View SEC filing
10-Q · Filed 2026-04-29View SEC filing
10-K · Filed 2026-02-18View SEC filing
10-Q · Filed 2025-10-29View SEC filing
10-Q · Filed 2025-07-30View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.